Device Medical Device

(1439) Hpm Undivided

Payments companies reported to CMS as associated with (1439) Hpm Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$7,547associated payments (2023-2025)
63clinicians with associated payments
2companies reporting

By year

2023 $4,317
2024 $3,230

Payments reported as associated with (1439) Hpm Undivided, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Acute Care (Nurse Practitioner) $1,291
Anesthesiology $1,180
Family $761
Nurse Anesthetist, Certified Registered $748
Adult Health (Nurse Practitioner) $480
Acute Care (Clinical Nurse Specialist) $447

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (1439) Hpm Undivided

These are the largest totals companies reported as associated with (1439) Hpm Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Olena Svetlov Calabasas, CA Acute Care (Clinical Nurse Specialist) $270.99
Ashish Khanna Winston Salem, NC Critical Care Medicine (Anesthesiology) $219.48
Flora Tomoyasu-Plowman San Juan Capistrano, CA $192.73
Theresa Haley Marina Del Rey, CA $144.11
Jose Chavez San Bernardino, CA Women'S Health (Clinical Nurse Specialist) $144.11
Taline Marcarian Beverly Hills, CA $144.11
Joyce Khremian San Dimas, CA Acute Care (Nurse Practitioner) $144.11
Mary Lawanson-Nichols Santa Monica, CA Acute Care (Clinical Nurse Specialist) $144.11
Eliza Granflor Rancho Cucamonga, CA Acute Care (Nurse Practitioner) $144.10
Danielle Chism Jacksonville, FL Internal Medicine $131.09

Prescribed (1439) Hpm Undivided?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.